DEEP HYPOTHERMIA THERAPY ATTENUATES LPS-INDUCED MICROGLIA NEUROINFLAMMATION VIA THE STAT3 PATHWAY
DEEP HYPOTHERMIA THERAPY ATTENUATES LPS-INDUCED MICROGLIA NEUROINFLAMMATION VIA THE STAT3 PATHWAY
复制标题
DOI:
10.1016/j.neuroscience.2017.06.055
复制
发表时间:
2017-09-01
期刊:
影响因子:
3.3
通讯作者:
Schmitt, K. R. L.
中科院分区:
文献类型:
--
作者:
Tong, G.;Krauss, A.;Schmitt, K. R. L.
Deep hypothermia therapy (HT) is a standard method for neuroprotection during complex pediatric cardiac surgery involving extracorporeal circulation and deep hypothermic cardiac arrest. The procedure, however, can provoke systemic inflammatory response syndrome (SIRS), one of the most severe side effects associated with pediatric cardiac surgery. To date, the cellular inflammatory mechanisms induced by deep HT remain to be elucidated. Therefore, we investigated the effects of deep HT (17 degrees C) and rewarming on the inflammatory response in lipopolysaccharide (LPS) stimulated BV-2 murine microglia. Additionally, we also investigated the application of Stattic, a signal transducer and activator of transcription 3 (STAT3) activation inhibitor, as an alternative to physical cooling to attenuate the LPS-induced inflammatory response. Deep HT had no cytotoxic effect but attenuated microglia migration. hcBa degradation was delayed by deep HT resulting in the attenuation of pNF-kappa B p65 migration into the nucleus and significant decreases in pro-inflammatory IL-6, TNF-alpha, and MCP-1 expressions and secretions, as well as decreased anti-inflammatory IL-10 and SOCS3 expressions. Additionally, pStat3 was significantly down regulated under deep hypothermic conditions, also corresponding with the significant reduction in IL-6 and TNF-alpha expressions. Similar to the effects of HT, the application of Stattic under normothermic conditions resulted in significantly reduced IL-6 and TNF-alpha expressions. Moreover, attenuation of the inflammatory response resulted in decreased apoptosis in a direct co culture of microglia and neurons. HT reduces the inflammatory response in LPS-stimulated BV-2 microglial cells, alluding to a possible mechanism of therapeutic hypothermia-induced neuroprotection. In the future, attenuating the phospho-STAT3 pathway may lead to the development of a neuroprotectant with greater clinical efficacy. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.